Henan Haitian Biotechnology Co Ltd

A GMP-certified veterinary drug manufacturer committed to long-term win-win partnership.

Henan Haitian Biotechnology Co Ltd
  • Home
  • About
  • Products
  • Contact
  • News
  • Home
  • About
  • Products
  • Contact
  • News
  • Meloxicam for Newborn Calves: What a 2026 Trial Found

    Meloxicam for newborn calves: a 2026 placebo-controlled trial in 151 Holstein-Friesian calves found that a single subcutaneous injection of 0.5 mg/kg meloxicam given immediately after birth raised vitality scores at 24 and 48 hours. The benefit showed up mainly in calves born from difficult calvings. Meloxicam did not correct the acidosis that comes with birth, and heart rate variability proved too weak to predict which calves would struggle. The practical takeaway: target meloxicam to assisted calvings rather than dosing the whole herd. Why newborn calf vitality matters more than it looks The first 48 hours of a calf’s life decide a large share of its future. Calves that stand slowly,…

    read more

    You May Also Like

    semisynthetic tetracycline derivatives tetracycline WHO essential medicines

    Tetracycline Antibiotics: 1,600 Years of History, Mechanism & Generations Explained

    May 1, 2026
    praziquantel chewable tablets for dogs

    How Dissolution Testing Ensures Your Dog’s Praziquantel Chewable Tablets Actually Work

    May 3, 2026

    FDA’s Approval of Faunamor: A Breakthrough for Ornamental Fish Health

    April 11, 2025
2026 Henan Haitian Biotechnology Co., Ltd. ©.
Ashe Theme by WP Royal.